<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2021.681668</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A Clinicopathological Analysis of Melanocytic Nevi: A Retrospective Series</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Panpan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1262741/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Su</surname> <given-names>Juan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zheng</surname> <given-names>Xuanwei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Mingliang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Xiang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/452700/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Jie</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1261414/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Peng</surname> <given-names>Cong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kuang</surname> <given-names>Yehong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhu</surname> <given-names>Wu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/921498/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Dermatology, Xiangya Hospital, Central South University</institution>, <addr-line>Changsha</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Hunan Key Laboratory of Skin Cancer and Psoriasis</institution>, <addr-line>Changsha</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Hunan Engineering Research Center of Skin Health and Disease</institution>, <addr-line>Changsha</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: H. Peter Soyer, The University of Queensland, Australia</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Katie June Lee, University of Queensland, Australia; Gerardo Ferrara, Ospedale Generale Provinciale Macerata, Italy</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Juan Su <email>540020068&#x00040;qq.com</email></corresp>
<corresp id="c002">Wu Zhu <email>zhuwu70&#x00040;hotmail.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Dermatology, a section of the journal Frontiers in Medicine</p></fn></author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>08</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>8</volume>
<elocation-id>681668</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>03</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>06</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2021 Liu, Su, Zheng, Chen, Chen, Li, Peng, Kuang and Zhu.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Liu, Su, Zheng, Chen, Chen, Li, Peng, Kuang and Zhu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p><bold>Purpose:</bold> Melanocytic nevi are common cutaneous lesions. This study aimed to demonstrate the concordance and discordance between clinical and histopathological diagnoses of melanocytic nevi and the importance of histological evaluation in differentiating malignant lesions from diseases with similar clinical manifestations.</p>
<p><bold>Patients and Methods:</bold> We studied 4,561 consecutive patients with a clinical diagnosis of melanocytic nevi from 2014 to 2019. We compared the clinical diagnosis with the histopathological diagnosis to establish a histopathological concordance rate and then investigated the effects of clinical characteristics and the reasons for removal on misclassification.</p>
<p><bold>Results:</bold> Among 4,561 patients who were clinically diagnosed with melanocytic nevi, the overall histopathological concordance rate was 82.11% (3,745 of 4,561 patients), while the histopathological discordance rate was 17.89% (816 of 4,561 patients). The histopathological concordance included 90.25% common acquired melanocytic nevi (3,380 of 3,745 patients) and 9.75% other benign melanocytic neoplasms (365 of 3,745 patients). The most common diagnostic change was to seborrheic keratosis (<italic>n</italic> = 470, 10.30%), followed by basal cell carcinoma (<italic>n</italic> = 64, 1.40%), vascular tumor (<italic>n</italic> = 53, 1.16%), fibroma (<italic>n</italic> = 43, 0.94%), epidermoid cyst (<italic>n</italic> = 34, 0.75%), wart (<italic>n</italic> = 30, 0.66%), melanoma (<italic>n</italic> = 24, 0.53%), Bowen&#x00027;s disease (<italic>n</italic> = 16, 0.35%), squamous cell carcinoma (<italic>n</italic> = 4, 0.09%), keratoacanthoma (<italic>n</italic> = 2, 0.04%), and other neoplasms (<italic>n</italic> = 76, 1.67%). Male sex, old age, location of the lesion, and the reasons for removal have a potential effect on misclassification. The percentages of misclassified lesions on the trunk and limbs and the perineum and buttocks were higher than those in lesions without a change in diagnosis. Importantly, locations of lesions on the head and neck were significantly related to a change in diagnosis to non-melanoma skin cancer, while locations on the hands and feet were significantly related to a change in diagnosis to melanoma. In addition to a typical clinical features, removal due to lesion changes or repeated stimulation was significantly associated with a change in diagnosis to melanoma.</p>
<p><bold>Conclusions:</bold> Our study emphasizes the clinical differential diagnosis of melanocytic nevi, especially the possibility of malignant tumors. The occurrence of clinical features associated with clinicopathological discordance should raise the clinical suspect and be carefully differentiated from malignant tumors.</p></abstract>
<kwd-group>
<kwd>melanocytic nevi</kwd>
<kwd>melanocytic diseases</kwd>
<kwd>melanoma</kwd>
<kwd>diagnosis</kwd>
<kwd>misclassification</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="36"/>
<page-count count="9"/>
<word-count count="6080"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Melanocytic nevi are benign tumors of melanocytes; these growths include common acquired melanocytic nevi and other benign melanocytic neoplasms, such as blue nevus, halo nevus, congenital nevomelanocytic nevus, &#x0201C;dysplastic&#x0201D; melanocytic nevus, and Spitz nevus (<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B3">3</xref>). Common acquired melanocytic nevi are the most frequent neoplasms. It is unnecessary to remove melanocytic nevi routinely, but they should be removed when any of the following conditions are met: changes in skin lesions, an atypical clinical appearance suspicious for melanoma, cosmetic requirements, or repeated stimulation (<xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>In fact, studies have found that common acquired melanocytic nevi are challenging to differentiate in clinical practice from other benign melanocytic neoplasms, such as congenital nevomelanocytic nevus and blue nevus, or even tumors, such as melanoma (<xref ref-type="bibr" rid="B5">5</xref>). Moreover, the importance of melanocytic nevi is related to melanoma. A large proportion of melanoma occur in the same area as long-term pre-existing melanocytic nevi (<xref ref-type="bibr" rid="B1">1</xref>). Histological examination has shown that approximately 30% of melanoma cases are associated with a residual nevus (<xref ref-type="bibr" rid="B6">6</xref>). Therefore, to provide support for clinicians in diagnosing and treating melanocytic nevi, our study focuses on patients with a clinical diagnosis of melanocytic nevi, which are reclassified after a histopathological examination, and assesses whether the clinical characteristics of patients affect the misclassification.</p></sec>
<sec id="s2">
<title>Patients and Methods</title>
<p>This is a retrospective review of data from 4,561 consecutive patients with a clinical diagnosis of melanocytic nevi over 5 years, from 2014 to 2019, referred to the Department of Dermatology of Xiangya Hospital, Central South University. All patients in this study had undergone an initial clinical diagnosis, excision, and histopathological diagnosis. The reasons for removal of melanocytic nevi included atypical clinical features, changes in skin lesions, cosmetic requirements, or repeated stimulation (e.g., sites of friction or repeated trauma) (<xref ref-type="bibr" rid="B4">4</xref>). To ensure accuracy, two independent dermatopathologists reviewed the hematoxylin-and-eosin-stained slides and made a diagnosis. If there is any disagreement among them, another dermatopathologist reviewed the slide, and the three dermatopathologists made the diagnosis together. Clinical data on each case, including the age and sex of the patient and the location of the lesion, were obtained from the patient records. This study was approved by the ethics committees of Xiangya Hospital of Central South University, Changsha, Hunan, China, and informed consent was obtained from all subjects.</p>
<p>The diagnosis and the classification of skin lesions were performed according to Fourth <italic>Edition Dermatology</italic> (edited by Bolognia, J. L.) (<xref ref-type="bibr" rid="B7">7</xref>). Histopathological concordance, which means the consistency of clinical and histopathological diagnoses, was assessed for neoplasms clinically diagnosed as melanocytic nevi and histopathologically diagnosed as common acquired melanocytic nevi or other benign melanocytic neoplasms, such as congenital nevomelanocytic nevus, blue nevus, lentigo, &#x0201C;dysplastic&#x0201D; melanocytic nevus, recurrent nevus, Spitz nevus, and halo nevus. Histopathological discordance, which means the inconsistency between clinical and histopathological diagnoses, included clinical diagnosis as melanocytic nevi and histopathological diagnosis as seborrheic keratosis, basal cell carcinoma, vascular tumor, fibroma, epidermoid cyst, wart, melanoma, Bowen&#x00027;s disease, squamous cell carcinoma, keratoacanthoma, and other neoplasms.</p>
<p>The records of 4,561 patients were reviewed to assess demographic and clinical factors, reasons for removal, and histopathological diagnosis. We first compared the clinical diagnosis with the histopathological diagnosis to establish a histopathological concordance rate and then investigated the effect of clinical characteristics and the reasons for removal on misclassification. Statistical analysis was performed using a &#x003C7;<sup>2</sup> test and Fisher&#x00027;s exact test. A two-tailed <italic>P</italic> &#x0003C; 0.05 was considered statistically significant. All statistical analyses were performed using the SPSS 23.0 statistical package (IBM SPSS, Chicago, IL, USA).</p></sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Histopathological Review</title>
<p>A total of 4,561 patients were clinically diagnosed with melanocytic nevi according to their skin lesions (<xref ref-type="fig" rid="F1">Figure 1</xref>). The characteristics of the patients are listed in <xref ref-type="table" rid="T1">Table 1</xref>. There were 1,459 males (31.99%) and 3,102 females (68.01%). The age ranged from 2 to 86 years, with a mean age of 31. The patients were divided into four groups based on age: &#x0003C;20, 20&#x02013;39, 40&#x02013;59, and &#x02265;60. The most common age range was 20&#x02013;39 years (54.70%), followed by &#x0003C;20 years (21.75%), while the least common age was &#x02265;60 years (4.71%). The head and neck (66.24%) were the most common sites of involvement, whereas, the hands (1.43%) and the buttocks (0.75%) were the least common sites of involvement. In addition, the most common reasons for removing melanocytic nevi were cosmetic requirements (48.78%) and atypical clinical features (47.18%).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Methodology of the study.</p></caption>
<graphic xlink:href="fmed-08-681668-g0001.tif"/>
</fig>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Clinical characteristics of 3,745 patients with a clinical diagnosis of melanocytic nevi with histopathological concordance.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="center" colspan="23" style="border-bottom: thin solid #000000;"><bold>Clinical diagnosis of melanocytic nevi with histopathological concordance</bold></th>
</tr>
<tr>
<th valign="top" align="left"><bold>Characteristic</bold></th>
<th/>
<th/>
<th valign="top" align="center" colspan="4" style="border-bottom: thin solid #000000;"><bold>Common acquired melanocytic nevi</bold></th>
<th valign="top" align="center" colspan="16" style="border-bottom: thin solid #000000;"><bold>Other benign melanocytic neoplasms</bold></th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th valign="top" align="center"><bold>Intradermal nevus (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold>Junctional nevus (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold>Compound nevus (<italic>N</italic>, %)</bold></th>
<th/>
<th valign="top" align="center"><bold>Congenital nevomelanocytic nevus (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P-</italic>value<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Blue nevus (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P-</italic>value<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Lentigo (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P-</italic>value<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>&#x0201C;Dysplastic&#x0201D; melanocytic nevus (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P-</italic>value<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Recurrent nevus (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P-</italic>value<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Spitz nevus (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P-</italic>value<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Halo nevus (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P-</italic>value<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Other melanocytic nevi<xref ref-type="table-fn" rid="TN2"><sup>b</sup></xref> (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P-</italic>value<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Number</td>
<td valign="top" align="center">4,561</td>
<td valign="top" align="center">3,745</td>
<td valign="top" align="center">2,598</td>
<td valign="top" align="center">238</td>
<td valign="top" align="center">544</td>
<td valign="top" align="center">3,380</td>
<td valign="top" align="center">114</td>
<td/>
<td valign="top" align="center">90</td>
<td/>
<td valign="top" align="center">64</td>
<td/>
<td valign="top" align="center">39</td>
<td/>
<td valign="top" align="center">17</td>
<td/>
<td valign="top" align="center">14</td>
<td/>
<td valign="top" align="center">12</td>
<td/>
<td valign="top" align="center">15</td>
<td/>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">82.11%</td>
<td valign="top" align="center">76.86%</td>
<td valign="top" align="center">7.04%</td>
<td valign="top" align="center">16.09%</td>
<td valign="top" align="center">90.25%</td>
<td valign="top" align="center">3.04%</td>
<td/>
<td valign="top" align="center">2.40%</td>
<td/>
<td valign="top" align="center">1.71%</td>
<td/>
<td valign="top" align="center">1.04%</td>
<td/>
<td valign="top" align="center">0.45%</td>
<td/>
<td valign="top" align="center">0.37%</td>
<td/>
<td valign="top" align="center">0.32%</td>
<td/>
<td valign="top" align="center">0.40%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Sex</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Male</td>
<td valign="top" align="center">1,459</td>
<td valign="top" align="center">1,099</td>
<td valign="top" align="center">739</td>
<td valign="top" align="center">71</td>
<td valign="top" align="center">171</td>
<td valign="top" align="center">981</td>
<td valign="top" align="center">34</td>
<td valign="top" align="center">0.853</td>
<td valign="top" align="center">35</td>
<td valign="top" align="center">0.042</td>
<td valign="top" align="center">21</td>
<td valign="top" align="center">0.509</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">0.811</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.195</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">1.000</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">0.336</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">0.714</td>
</tr>
<tr>
<td/>
<td valign="top" align="center">31.99%</td>
<td valign="top" align="center">29.35%</td>
<td valign="top" align="center">28.44%</td>
<td valign="top" align="center">29.83%</td>
<td valign="top" align="center">31.43%</td>
<td valign="top" align="center">29.02%</td>
<td valign="top" align="center">29.82%</td>
<td/>
<td valign="top" align="center">38.89%</td>
<td/>
<td valign="top" align="center">32.81%</td>
<td/>
<td valign="top" align="center">30.77%</td>
<td/>
<td valign="top" align="center">11.76%</td>
<td/>
<td valign="top" align="center">28.57%</td>
<td/>
<td valign="top" align="center">41.67%</td>
<td/>
<td valign="top" align="center">33.33%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Female</td>
<td valign="top" align="center">3,102</td>
<td valign="top" align="center">2,646</td>
<td valign="top" align="center">1,859</td>
<td valign="top" align="center">167</td>
<td valign="top" align="center">373</td>
<td valign="top" align="center">2,399</td>
<td valign="top" align="center">80</td>
<td/>
<td valign="top" align="center">55</td>
<td/>
<td valign="top" align="center">43</td>
<td/>
<td valign="top" align="center">27</td>
<td/>
<td valign="top" align="center">15</td>
<td/>
<td valign="top" align="center">10</td>
<td/>
<td valign="top" align="center">7</td>
<td/>
<td valign="top" align="center">10</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">68.01%</td>
<td valign="top" align="center">70.65%</td>
<td valign="top" align="center">71.56%</td>
<td valign="top" align="center">70.17%</td>
<td valign="top" align="center">68.57%</td>
<td valign="top" align="center">70.98%</td>
<td valign="top" align="center">70.18%</td>
<td/>
<td valign="top" align="center">61.11%</td>
<td/>
<td valign="top" align="center">67.19%</td>
<td/>
<td valign="top" align="center">69.23%</td>
<td/>
<td valign="top" align="center">88.24%</td>
<td/>
<td valign="top" align="center">71.43%</td>
<td/>
<td valign="top" align="center">58.33%</td>
<td/>
<td valign="top" align="center">66.67%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Age</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">0.009</td>
<td/>
<td valign="top" align="center">0.216</td>
<td/>
<td valign="top" align="center">0.364</td>
<td/>
<td valign="top" align="center">0.625</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">1.000</td>
<td/>
<td valign="top" align="center">0.288</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Mean</td>
<td valign="top" align="center">31</td>
<td valign="top" align="center">27</td>
<td valign="top" align="center">31</td>
<td valign="top" align="center">29</td>
<td valign="top" align="center">28</td>
<td valign="top" align="center">27</td>
<td valign="top" align="center">20</td>
<td/>
<td valign="top" align="center">31</td>
<td/>
<td valign="top" align="center">28</td>
<td/>
<td valign="top" align="center">23</td>
<td/>
<td valign="top" align="center">23</td>
<td/>
<td valign="top" align="center">12</td>
<td/>
<td valign="top" align="center">27</td>
<td/>
<td valign="top" align="center">23</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Range</td>
<td valign="top" align="center">2&#x02013;86</td>
<td valign="top" align="center">2&#x02013;80</td>
<td valign="top" align="center">5&#x02013;76</td>
<td valign="top" align="center">2&#x02013;80</td>
<td valign="top" align="center">5&#x02013;76</td>
<td valign="top" align="center">2&#x02013;80</td>
<td valign="top" align="center">6&#x02013;52</td>
<td/>
<td valign="top" align="center">9&#x02013;79</td>
<td/>
<td valign="top" align="center">7&#x02013;62</td>
<td/>
<td valign="top" align="center">8&#x02013;44</td>
<td/>
<td valign="top" align="center">7&#x02013;51</td>
<td/>
<td valign="top" align="center">3&#x02013;29</td>
<td/>
<td valign="top" align="center">13&#x02013;57</td>
<td/>
<td valign="top" align="center">7&#x02013;51</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x0003C;20</td>
<td valign="top" align="center">992</td>
<td valign="top" align="center">958</td>
<td valign="top" align="center">530</td>
<td valign="top" align="center">54</td>
<td valign="top" align="center">243</td>
<td valign="top" align="center">827</td>
<td valign="top" align="center">62</td>
<td/>
<td valign="top" align="center">19</td>
<td/>
<td valign="top" align="center">9</td>
<td/>
<td valign="top" align="center">13</td>
<td/>
<td valign="top" align="center">6</td>
<td/>
<td valign="top" align="center">12</td>
<td/>
<td valign="top" align="center">3</td>
<td/>
<td valign="top" align="center">7</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">21.75%</td>
<td valign="top" align="center">25.58%</td>
<td valign="top" align="center">20.40%</td>
<td valign="top" align="center">22.69%</td>
<td valign="top" align="center">44.67%</td>
<td valign="top" align="center">24.47%</td>
<td valign="top" align="center">54.39%</td>
<td/>
<td valign="top" align="center">21.11%</td>
<td/>
<td valign="top" align="center">14.06%</td>
<td/>
<td valign="top" align="center">33.33%</td>
<td/>
<td valign="top" align="center">35.29%</td>
<td/>
<td valign="top" align="center">85.71%</td>
<td/>
<td valign="top" align="center">25.00%</td>
<td/>
<td valign="top" align="center">46.67%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;20&#x02013;39</td>
<td valign="top" align="center">2,495</td>
<td valign="top" align="center">2,250</td>
<td valign="top" align="center">1,651</td>
<td valign="top" align="center">144</td>
<td valign="top" align="center">268</td>
<td valign="top" align="center">2,063</td>
<td valign="top" align="center">40</td>
<td/>
<td valign="top" align="center">50</td>
<td/>
<td valign="top" align="center">46</td>
<td/>
<td valign="top" align="center">24</td>
<td/>
<td valign="top" align="center">10</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">8</td>
<td/>
<td valign="top" align="center">7</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">54.70%</td>
<td valign="top" align="center">60.08%</td>
<td valign="top" align="center">63.55%</td>
<td valign="top" align="center">60.50%</td>
<td valign="top" align="center">49.26%</td>
<td valign="top" align="center">61.04%</td>
<td valign="top" align="center">35.09%</td>
<td/>
<td valign="top" align="center">55.56%</td>
<td/>
<td valign="top" align="center">71.88%</td>
<td/>
<td valign="top" align="center">61.54%</td>
<td/>
<td valign="top" align="center">58.82%</td>
<td/>
<td valign="top" align="center">14.29%</td>
<td/>
<td valign="top" align="center">66.67%</td>
<td/>
<td valign="top" align="center">46.67%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;40&#x02013;59</td>
<td valign="top" align="center">859</td>
<td valign="top" align="center">481</td>
<td valign="top" align="center">379</td>
<td valign="top" align="center">32</td>
<td valign="top" align="center">29</td>
<td valign="top" align="center">440</td>
<td valign="top" align="center">12</td>
<td/>
<td valign="top" align="center">16</td>
<td/>
<td valign="top" align="center">8</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">18.83%</td>
<td valign="top" align="center">12.84%</td>
<td valign="top" align="center">14.59%</td>
<td valign="top" align="center">13.45%</td>
<td valign="top" align="center">5.33%</td>
<td valign="top" align="center">13.02%</td>
<td valign="top" align="center">10.53%</td>
<td/>
<td valign="top" align="center">17.78%</td>
<td/>
<td valign="top" align="center">12.50%</td>
<td/>
<td valign="top" align="center">5.13%</td>
<td/>
<td valign="top" align="center">5.88%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">8.33%</td>
<td/>
<td valign="top" align="center">6.67%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x02265;60</td>
<td valign="top" align="center">215</td>
<td valign="top" align="center">56</td>
<td valign="top" align="center">38</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">50</td>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">5</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">4.71%</td>
<td valign="top" align="center">1.50%</td>
<td valign="top" align="center">1.46%</td>
<td valign="top" align="center">3.36%</td>
<td valign="top" align="center">0.74%</td>
<td valign="top" align="center">1.48%</td>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">5.56%</td>
<td/>
<td valign="top" align="center">1.56%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Location</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td valign="top" align="center">0.068</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">0.534</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">0.964</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Head and neck</td>
<td valign="top" align="center">3,021</td>
<td valign="top" align="center">2,628</td>
<td valign="top" align="center">2,067</td>
<td valign="top" align="center">32</td>
<td valign="top" align="center">335</td>
<td valign="top" align="center">2,434</td>
<td valign="top" align="center">89</td>
<td/>
<td valign="top" align="center">38</td>
<td/>
<td valign="top" align="center">13</td>
<td/>
<td valign="top" align="center">16</td>
<td/>
<td valign="top" align="center">16</td>
<td/>
<td valign="top" align="center">8</td>
<td/>
<td valign="top" align="center">10</td>
<td/>
<td valign="top" align="center">4</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">66.24%</td>
<td valign="top" align="center">70.17%</td>
<td valign="top" align="center">79.56%</td>
<td valign="top" align="center">13.45%</td>
<td valign="top" align="center">61.58%</td>
<td valign="top" align="center">72.01%</td>
<td valign="top" align="center">78.07%</td>
<td/>
<td valign="top" align="center">42.22%</td>
<td/>
<td valign="top" align="center">20.31%</td>
<td/>
<td valign="top" align="center">41.03%</td>
<td/>
<td valign="top" align="center">94.12%</td>
<td/>
<td valign="top" align="center">57.14%</td>
<td/>
<td valign="top" align="center">83.33%</td>
<td/>
<td valign="top" align="center">26.67%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Upper limbs</td>
<td valign="top" align="center">149</td>
<td valign="top" align="center">118</td>
<td valign="top" align="center">61</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">27</td>
<td valign="top" align="center">92</td>
<td valign="top" align="center">7</td>
<td/>
<td valign="top" align="center">15</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">3.27%</td>
<td valign="top" align="center">3.15%</td>
<td valign="top" align="center">2.35%</td>
<td valign="top" align="center">1.68%</td>
<td valign="top" align="center">4.96%</td>
<td valign="top" align="center">2.72%</td>
<td valign="top" align="center">6.14%</td>
<td/>
<td valign="top" align="center">16.67%</td>
<td/>
<td valign="top" align="center">1.56%</td>
<td/>
<td valign="top" align="center">5.13%</td>
<td/>
<td valign="top" align="center">5.88%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Lower limbs</td>
<td valign="top" align="center">168</td>
<td valign="top" align="center">109</td>
<td valign="top" align="center">39</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">34</td>
<td valign="top" align="center">81</td>
<td valign="top" align="center">4</td>
<td/>
<td valign="top" align="center">7</td>
<td/>
<td valign="top" align="center">4</td>
<td/>
<td valign="top" align="center">7</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">4</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">3.68%</td>
<td valign="top" align="center">2.91%</td>
<td valign="top" align="center">1.50%</td>
<td valign="top" align="center">3.36%</td>
<td valign="top" align="center">6.25%</td>
<td valign="top" align="center">2.40%</td>
<td valign="top" align="center">3.51%</td>
<td/>
<td valign="top" align="center">7.78%</td>
<td/>
<td valign="top" align="center">6.25%</td>
<td/>
<td valign="top" align="center">17.95%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">14.29%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">26.67%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Trunk</td>
<td valign="top" align="center">763</td>
<td valign="top" align="center">522</td>
<td valign="top" align="center">375</td>
<td valign="top" align="center">32</td>
<td valign="top" align="center">73</td>
<td valign="top" align="center">480</td>
<td valign="top" align="center">12</td>
<td/>
<td valign="top" align="center">3</td>
<td/>
<td valign="top" align="center">10</td>
<td/>
<td valign="top" align="center">9</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">5</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">16.73%</td>
<td valign="top" align="center">13.94%</td>
<td valign="top" align="center">14.43%</td>
<td valign="top" align="center">13.45%</td>
<td valign="top" align="center">13.42%</td>
<td valign="top" align="center">14.20%</td>
<td valign="top" align="center">10.53%</td>
<td/>
<td valign="top" align="center">3.33%</td>
<td/>
<td valign="top" align="center">15.63%</td>
<td/>
<td valign="top" align="center">23.08%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">7.14%</td>
<td/>
<td valign="top" align="center">16.67%</td>
<td/>
<td valign="top" align="center">33.33%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Perineum</td>
<td valign="top" align="center">108</td>
<td valign="top" align="center">60</td>
<td valign="top" align="center">27</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">49</td>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">10</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">2.37%</td>
<td valign="top" align="center">1.60%</td>
<td valign="top" align="center">1.04%</td>
<td valign="top" align="center">4.20%</td>
<td valign="top" align="center">2.21%</td>
<td valign="top" align="center">1.45%</td>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">15.63%</td>
<td/>
<td valign="top" align="center">2.56%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Hands</td>
<td valign="top" align="center">65</td>
<td valign="top" align="center">57</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">21</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">34</td>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">14</td>
<td/>
<td valign="top" align="center">8</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">1.43%</td>
<td valign="top" align="center">1.52%</td>
<td valign="top" align="center">0.27%</td>
<td valign="top" align="center">8.82%</td>
<td valign="top" align="center">1.10%</td>
<td valign="top" align="center">1.01%</td>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">15.56%</td>
<td/>
<td valign="top" align="center">12.50%</td>
<td/>
<td valign="top" align="center">2.56%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Feet</td>
<td valign="top" align="center">253</td>
<td valign="top" align="center">228</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">131</td>
<td valign="top" align="center">53</td>
<td valign="top" align="center">196</td>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">8</td>
<td/>
<td valign="top" align="center">18</td>
<td/>
<td valign="top" align="center">3</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">5.55%</td>
<td valign="top" align="center">6.09%</td>
<td valign="top" align="center">0.46%</td>
<td valign="top" align="center">55.04%</td>
<td valign="top" align="center">9.74%</td>
<td valign="top" align="center">5.80%</td>
<td valign="top" align="center">1.75%</td>
<td/>
<td valign="top" align="center">8.89%</td>
<td/>
<td valign="top" align="center">28.13%</td>
<td/>
<td valign="top" align="center">7.69%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">7.14%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Buttocks</td>
<td valign="top" align="center">34</td>
<td valign="top" align="center">23</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">14</td>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">5</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">0.75%</td>
<td valign="top" align="center">0.61%</td>
<td valign="top" align="center">0.38%</td>
<td valign="top" align="center">0.00%</td>
<td valign="top" align="center">0.74%</td>
<td valign="top" align="center">0.41%</td>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">5.56%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">14.29%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">13.33%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Reason for removal</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td valign="top" align="center">0.002</td>
<td/>
<td valign="top" align="center">0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">0.319</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">0.135</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">0.204</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Atypical clinical features</td>
<td valign="top" align="center">2,152</td>
<td valign="top" align="center">1,566</td>
<td valign="top" align="center">1,051</td>
<td valign="top" align="center">92</td>
<td valign="top" align="center">218</td>
<td valign="top" align="center">1,361</td>
<td valign="top" align="center">67</td>
<td/>
<td valign="top" align="center">53</td>
<td/>
<td valign="top" align="center">27</td>
<td/>
<td valign="top" align="center">20</td>
<td/>
<td valign="top" align="center">6</td>
<td/>
<td valign="top" align="center">10</td>
<td/>
<td valign="top" align="center">12</td>
<td/>
<td valign="top" align="center">10</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">47.18%</td>
<td valign="top" align="center">41.82%</td>
<td valign="top" align="center">40.45%</td>
<td valign="top" align="center">38.66%</td>
<td valign="top" align="center">40.07%</td>
<td valign="top" align="center">40.27%</td>
<td valign="top" align="center">58.77%</td>
<td/>
<td valign="top" align="center">58.89%</td>
<td/>
<td valign="top" align="center">42.19%</td>
<td/>
<td valign="top" align="center">51.28%</td>
<td/>
<td valign="top" align="center">35.29%</td>
<td/>
<td valign="top" align="center">71.43%</td>
<td/>
<td valign="top" align="center">100.00%</td>
<td/>
<td valign="top" align="center">66.67%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Changes in skin lesions</td>
<td valign="top" align="center">30</td>
<td valign="top" align="center">18</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">3</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">0.66%</td>
<td valign="top" align="center">0.48%</td>
<td valign="top" align="center">0.35%</td>
<td valign="top" align="center">0.00%</td>
<td valign="top" align="center">0.55%</td>
<td valign="top" align="center">0.36%</td>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">1.11%</td>
<td/>
<td valign="top" align="center">3.13%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">17.65%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Cosmetic requirements</td>
<td valign="top" align="center">2,225</td>
<td valign="top" align="center">2,015</td>
<td valign="top" align="center">1,515</td>
<td valign="top" align="center">80</td>
<td valign="top" align="center">285</td>
<td valign="top" align="center">1,880</td>
<td valign="top" align="center">45</td>
<td/>
<td valign="top" align="center">36</td>
<td/>
<td valign="top" align="center">23</td>
<td/>
<td valign="top" align="center">17</td>
<td/>
<td valign="top" align="center">5</td>
<td/>
<td valign="top" align="center">4</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">5</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">48.78%</td>
<td valign="top" align="center">53.81%</td>
<td valign="top" align="center">58.31%</td>
<td valign="top" align="center">33.61%</td>
<td valign="top" align="center">52.39%</td>
<td valign="top" align="center">55.62%</td>
<td valign="top" align="center">39.47%</td>
<td/>
<td valign="top" align="center">40.00%</td>
<td/>
<td valign="top" align="center">35.94%</td>
<td/>
<td valign="top" align="center">43.59%</td>
<td/>
<td valign="top" align="center">29.41%</td>
<td/>
<td valign="top" align="center">28.57%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">33.33%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Repeated stimulation</td>
<td valign="top" align="center">154</td>
<td valign="top" align="center">146</td>
<td valign="top" align="center">23</td>
<td valign="top" align="center">66</td>
<td valign="top" align="center">38</td>
<td valign="top" align="center">127</td>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">12</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">3</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">3.38%</td>
<td valign="top" align="center">3.90%</td>
<td valign="top" align="center">0.89%</td>
<td valign="top" align="center">27.73%</td>
<td valign="top" align="center">6.99%</td>
<td valign="top" align="center">3.76%</td>
<td valign="top" align="center">1.75%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">18.75%</td>
<td/>
<td valign="top" align="center">5.13%</td>
<td/>
<td valign="top" align="center">17.65%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1">
<label>a</label>
<p><italic>Demographic comparison was made between the common acquired melanocytic nevi group and other benign melanocytic neoplasms group</italic>.</p></fn>
<fn id="TN2">
<label>b</label>
<p><italic>Other melanocytic neoplasms include five spindle cell nevus of Reed, three Becker&#x00027;s nevus, two deep penetrating nevus, one nevus of Ota, one nevus of Ito, and three nevus spilus</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>After a histopathological examination, 3,745 patients were finally diagnosed with melanocytic nevi (overall histopathological concordance rate, 82.11%), while 816 patients clinically diagnosed with melanocytic nevi were reclassified as other diseases (overall histopathological discordance rate 17.89%; <xref ref-type="fig" rid="F1">Figure 1</xref>; <xref ref-type="table" rid="T1">Tables 1</xref>, <xref ref-type="table" rid="T2">2</xref>).</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Histopathological diagnosis distribution of 816 patients whose clinical diagnosis was not congruent with the histopathological diagnosis.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Histopathological diagnosis</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Clinical diagnosis of melanocytic nevi</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>No. of patients</bold></th>
<th valign="top" align="center"><bold>%</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Overall histopathological discordance</td>
<td valign="top" align="center">816</td>
<td valign="top" align="center">17.89</td>
</tr>
<tr>
<td valign="top" align="left">Seborrheic keratosis</td>
<td valign="top" align="center">470</td>
<td valign="top" align="center">10.30</td>
</tr>
<tr>
<td valign="top" align="left">Basal cell carcinoma</td>
<td valign="top" align="center">64</td>
<td valign="top" align="center">1.40</td>
</tr>
<tr>
<td valign="top" align="left">Vascular tumor</td>
<td valign="top" align="center">53</td>
<td valign="top" align="center">1.16</td>
</tr>
<tr>
<td valign="top" align="left">Fibroma</td>
<td valign="top" align="center">43</td>
<td valign="top" align="center">0.94</td>
</tr>
<tr>
<td valign="top" align="left">Epidermoid cyst</td>
<td valign="top" align="center">34</td>
<td valign="top" align="center">0.75</td>
</tr>
<tr>
<td valign="top" align="left">Wart</td>
<td valign="top" align="center">30</td>
<td valign="top" align="center">0.66</td>
</tr>
<tr>
<td valign="top" align="left">Melanoma</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">0.53</td>
</tr>
<tr>
<td valign="top" align="left">Bowen&#x00027;s disease</td>
<td valign="top" align="center">16</td>
<td valign="top" align="center">0.35</td>
</tr>
<tr>
<td valign="top" align="left">Squamous cell carcinoma</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">0.09</td>
</tr>
<tr>
<td valign="top" align="left">Keratoacanthoma</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0.04</td>
</tr>
<tr>
<td valign="top" align="left">Other<xref ref-type="table-fn" rid="TN3"><sup>a</sup></xref></td>
<td valign="top" align="center">76</td>
<td valign="top" align="center">1.67</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN3">
<label>a</label>
<p><italic>Other include nine granuloma, six sebaceous hyperplasia, six scar, four lichenoid keratosis, one Darier disease, two xanthogranuloma, five dermatitis, three blood blister, two venous lakes, one folliculitis, one cutaneous amyloidosis, one mucinosis, one solar keratosis, one trichilemmal cyst, two lichen sclerosus et atrophicus, four fibrous papule of nose, two Fordyce disease, three hamartomas, one mixed tumor, four trichoepithelioma, four pilomatricoma, two syringoma, one poroma, one hidradenoma, one sebaceoma, one plexiform schwannoma, one xanthoma, three lymphangioma, one clear cell acanthoma, one dermal duct tumor, and one steatocystoma</italic>.</p></fn>
</table-wrap-foot>
</table-wrap></sec>
<sec>
<title>Histopathological Concordance and Its Clinical Characteristics</title>
<p>The histopathologically concordant cases included common acquired melanocytic nevi (<italic>n</italic> = 3,380, 90.25%) and other benign melanocytic neoplasms (365, 9.75%; <xref ref-type="table" rid="T1">Table 1</xref>). Common acquired melanocytic nevi were divided into intradermal nevus (<italic>n</italic> = 2,598, 76.86%), junctional nevus (<italic>n</italic> = 238, 7.04%), and compound nevus (544, 16.09%; <xref ref-type="table" rid="T1">Table 1</xref>). The ratio of males to females was roughly the same in all three type-based groups (overall, 981:2,399; 29.02:70.98%). The most common age range was 20&#x02013;39 years (61.04%), followed by &#x0003C;20 years (24.47%). The most common sites of involvement for intradermal nevus and compound nevus were the head and neck (79.56 and 61.58%, respectively), followed by the trunk (14.43 and 13.42%, respectively). However, the most common site of involvement in the junctional nevus group was the feet (55.04%), followed by the head and neck (13.45%) and the trunk (13.45%). The main reasons for removing common acquired melanocytic nevi were cosmetic requirements and atypical clinical features. Interestingly, in the junctional nevus group, 27.73% of the lesions were removed because of repeated stimulation, which was significantly higher than the corresponding rates in the intradermal nevus and compound nevus groups (0.89 and 6.99%, respectively).</p>
<p>The other benign melanocytic neoplasms included congenital nevomelanocytic nevus (3.04%), blue nevus (2.40%), lentigo (1.71%), &#x0201C;dysplastic&#x0201D; melanocytic nevus (1.04%), recurrent nevus (0.45%), Spitz nevus (0.37%), halo nevus (0.32%), and other melanocytic nevi (0.40%). We evaluated clinical characteristics that could potentially have an impact on the classification of other benign melanocytic neoplasms. Younger age was significantly associated with the histopathological diagnosis of congenital nevomelanocytic nevus and Spitz nevus, compared with the common acquired melanocytic nevi. The most common age group in the classification of congenital nevomelanocytic nevus and Spitz nevus was &#x0003C;20 years (54.39 and 85.71%, respectively), compared with 20&#x02013;39 years (61.04%) in patients with a histopathological diagnosis of common acquired melanocytic nevi (<xref ref-type="table" rid="T1">Table 1</xref>). Furthermore, the location of the lesion was significantly correlated with the diagnosis of blue nevus, lentigo, and &#x0201C;dysplastic&#x0201D; melanocytic nevus (<xref ref-type="table" rid="T1">Table 1</xref>). The percentages of blue nevus lesions occurring on the upper limbs and hands, lentigo lesions on the feet, and &#x0201C;dysplastic&#x0201D; melanocytic nevus lesions on the lower limbs were higher than those in patients with a histopathological diagnosis of common acquired melanocytic nevi (<xref ref-type="table" rid="T1">Table 1</xref>). The reasons for removing melanocytic nevi also influenced the classification of congenital nevomelanocytic nevus, blue nevus, lentigo, recurrent nevus, and halo nevus. In the lentigo and recurrent nevus groups, in addition to atypical clinical features, the percentage of lesions removed due to lesion changes and repeated stimulation was significantly higher for lesions histopathologically diagnosed as common acquired melanocytic nevi (<xref ref-type="table" rid="T1">Table 1</xref>).</p></sec>
<sec>
<title>Clinical Characteristics Have a Potential Effect on Misclassification</title>
<p>Histopathological review led to a change in diagnosis in a total of 816 of 4,561 patients (17.89%; <xref ref-type="fig" rid="F1">Figure 1</xref> and <xref ref-type="table" rid="T2">Table 2</xref>), including seborrheic keratosis (<italic>n</italic> = 470, 10.30%), basal cell carcinoma (<italic>n</italic> = 64, 1.40%), vascular tumor (<italic>n</italic> = 53, 1.16%), fibroma (<italic>n</italic> = 43, 0.94%), epidermoid cyst (<italic>n</italic> = 34, 0.75%), wart (<italic>n</italic> = 30, 0.66%), melanoma (<italic>n</italic> = 24, 0.53%), Bowen&#x00027;s disease (<italic>n</italic> = 16, 0.35%), squamous cell carcinoma (<italic>n</italic> = 4, 0.09%), keratoacanthoma (<italic>n</italic> = 2, 0.04%), and other neoplasms (<italic>n</italic> = 76, 1.67%).</p>
<p>We evaluated clinical characteristics that could potentially have an impact on misclassification. Among patients with a clinical diagnosis of melanocytic nevi, male sex was significantly related to a change in diagnosis (overall histopathological concordance vs. overall histopathological discordance, <italic>p</italic> &#x0003C; 0.001; <xref ref-type="table" rid="T3">Table 3</xref>). In addition, old age was also significantly associated with a change in diagnosis (<italic>p</italic> &#x0003C; 0.001; <xref ref-type="table" rid="T3">Table 3</xref>). The median age of diagnosis of patients with misclassification was 45 years (range, 2&#x02013;86 years), compared with 27 years (range, 2&#x02013;80 years) in patients with histopathological concordance. Interestingly, the location of the lesion was significantly correlated with histopathological discordance (<italic>p</italic> &#x0003C; 0.001; <xref ref-type="table" rid="T3">Table 3</xref>). The percentages of misclassified lesions on the trunk and limbs and the perineum and buttocks were 40.69 and 7.11%, respectively, compared with 20.00 and 2.22%, respectively, in lesions without a change in diagnosis (<xref ref-type="table" rid="T3">Table 3</xref>). The reasons for removing melanocytic nevi also influenced the change in diagnosis. The proportion of misclassified lesions removed due to atypical clinical features was 71.81%, compared with 41.82% among lesions with histopathological concordance (<italic>p</italic> &#x0003C; 0.001; <xref ref-type="table" rid="T3">Table 3</xref>). Therefore, sex, age, location of the lesion, and reasons for removal all have a potential effect on misclassification.</p>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p>Clinical characteristics of patients with histopathological concordance or histopathological discordance.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="center" colspan="17" style="border-bottom: thin solid #000000;"><bold>Clinical diagnosis of melanocytic nevi</bold></th>
</tr>
<tr>
<th valign="top" align="left"><bold>Characteristic</bold></th>
<th/>
<th/>
<th valign="top" align="center" colspan="14" style="border-bottom: thin solid #000000;"><bold>Histopathological discordance</bold></th>
</tr>
<tr>
<th/>
<th/>
<th valign="top" align="center"><bold>Overall histopathological concordance (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold>Overall histopathological discordance (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value<xref ref-type="table-fn" rid="TN4"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Seborrheic keratosis (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value<xref ref-type="table-fn" rid="TN4"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Basal cell carcinoma (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value<xref ref-type="table-fn" rid="TN4"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Melanoma (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value<xref ref-type="table-fn" rid="TN4"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Bowen&#x00027;s disease (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value<xref ref-type="table-fn" rid="TN4"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Squamous cell carcinoma (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value<xref ref-type="table-fn" rid="TN4"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Keratoacanthoma (<italic>N</italic>, %)</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value<xref ref-type="table-fn" rid="TN4"><sup>a</sup></xref></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Number</td>
<td valign="top" align="center">4,561</td>
<td valign="top" align="center">3,745</td>
<td valign="top" align="center">816</td>
<td/>
<td valign="top" align="center">470</td>
<td/>
<td valign="top" align="center">64</td>
<td/>
<td valign="top" align="center">24</td>
<td/>
<td valign="top" align="center">16</td>
<td/>
<td valign="top" align="center">4</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">82.11%</td>
<td valign="top" align="center">17.89%</td>
<td/>
<td valign="top" align="center">10.30%</td>
<td/>
<td valign="top" align="center">1.40%</td>
<td/>
<td valign="top" align="center">0.53%</td>
<td/>
<td valign="top" align="center">0.35%</td>
<td/>
<td valign="top" align="center">0.09%</td>
<td/>
<td valign="top" align="center">0.04%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Sex</td>
<td/>
<td/>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">0.077</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">0.721</td>
<td/>
<td valign="top" align="center">1.000</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Male</td>
<td valign="top" align="center">1,459</td>
<td valign="top" align="center">1,099</td>
<td valign="top" align="center">360</td>
<td/>
<td valign="top" align="center">201</td>
<td/>
<td valign="top" align="center">37</td>
<td/>
<td valign="top" align="center">11</td>
<td/>
<td valign="top" align="center">13</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">31.99%</td>
<td valign="top" align="center">29.35%</td>
<td valign="top" align="center">44.12%</td>
<td/>
<td valign="top" align="center">42.77%</td>
<td/>
<td valign="top" align="center">57.81%</td>
<td/>
<td valign="top" align="center">45.83%</td>
<td/>
<td valign="top" align="center">81.25%</td>
<td/>
<td valign="top" align="center">50.00%</td>
<td/>
<td valign="top" align="center">50.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Female</td>
<td valign="top" align="center">3,102</td>
<td valign="top" align="center">2,646</td>
<td valign="top" align="center">456</td>
<td/>
<td valign="top" align="center">269</td>
<td/>
<td valign="top" align="center">27</td>
<td/>
<td valign="top" align="center">13</td>
<td/>
<td valign="top" align="center">3</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">68.01%</td>
<td valign="top" align="center">70.65%</td>
<td valign="top" align="center">55.88%</td>
<td/>
<td valign="top" align="center">57.23%</td>
<td/>
<td valign="top" align="center">42.19%</td>
<td/>
<td valign="top" align="center">54.17%</td>
<td/>
<td valign="top" align="center">18.75%</td>
<td/>
<td valign="top" align="center">50.00%</td>
<td/>
<td valign="top" align="center">50.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Age</td>
<td/>
<td/>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">0.007</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Mean</td>
<td valign="top" align="center">31</td>
<td valign="top" align="center">27</td>
<td valign="top" align="center">45</td>
<td/>
<td valign="top" align="center">48</td>
<td/>
<td valign="top" align="center">55</td>
<td/>
<td valign="top" align="center">50</td>
<td/>
<td valign="top" align="center">43</td>
<td/>
<td valign="top" align="center">49</td>
<td/>
<td valign="top" align="center">63</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Range</td>
<td valign="top" align="center">2&#x02013;86</td>
<td valign="top" align="center">2&#x02013;80</td>
<td valign="top" align="center">2&#x02013;86</td>
<td/>
<td valign="top" align="center">3&#x02013;86</td>
<td/>
<td valign="top" align="center">21&#x02013;80</td>
<td/>
<td valign="top" align="center">17&#x02013;73</td>
<td/>
<td valign="top" align="center">25&#x02013;69</td>
<td/>
<td valign="top" align="center">34&#x02013;64</td>
<td/>
<td valign="top" align="center">50&#x02013;76</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x0003C;60</td>
<td valign="top" align="center">4,346</td>
<td valign="top" align="center">3,689</td>
<td valign="top" align="center">657</td>
<td/>
<td valign="top" align="center">376</td>
<td/>
<td valign="top" align="center">39</td>
<td/>
<td valign="top" align="center">14</td>
<td/>
<td valign="top" align="center">12</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">95.29%</td>
<td valign="top" align="center">98.50%</td>
<td valign="top" align="center">80.51%</td>
<td/>
<td valign="top" align="center">80.00%</td>
<td/>
<td valign="top" align="center">60.94%</td>
<td/>
<td valign="top" align="center">58.33%</td>
<td/>
<td valign="top" align="center">75.00%</td>
<td/>
<td valign="top" align="center">50.00%</td>
<td/>
<td valign="top" align="center">50.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x02265;60</td>
<td valign="top" align="center">215</td>
<td valign="top" align="center">56</td>
<td valign="top" align="center">159</td>
<td/>
<td valign="top" align="center">94</td>
<td/>
<td valign="top" align="center">25</td>
<td/>
<td valign="top" align="center">10</td>
<td/>
<td valign="top" align="center">4</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">4.71%</td>
<td valign="top" align="center">1.50%</td>
<td valign="top" align="center">19.49%</td>
<td/>
<td valign="top" align="center">20.00%</td>
<td/>
<td valign="top" align="center">39.06%</td>
<td/>
<td valign="top" align="center">41.67%</td>
<td/>
<td valign="top" align="center">25.00%</td>
<td/>
<td valign="top" align="center">50.00%</td>
<td/>
<td valign="top" align="center">50.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Location</td>
<td/>
<td/>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">0.723</td>
<td/>
<td valign="top" align="center">1.000</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Head and neck</td>
<td valign="top" align="center">3,021</td>
<td valign="top" align="center">2,628</td>
<td valign="top" align="center">393</td>
<td/>
<td valign="top" align="center">218</td>
<td/>
<td valign="top" align="center">59</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
<td valign="top" align="center">4</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">66.24%</td>
<td valign="top" align="center">70.17%</td>
<td valign="top" align="center">48.16%</td>
<td/>
<td valign="top" align="center">46.38%</td>
<td/>
<td valign="top" align="center">92.19%</td>
<td/>
<td valign="top" align="center">4.17%</td>
<td/>
<td valign="top" align="center">6.25%</td>
<td/>
<td valign="top" align="center">100.00%</td>
<td/>
<td valign="top" align="center">100.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Trunk and limbs</td>
<td valign="top" align="center">1,081</td>
<td valign="top" align="center">749</td>
<td valign="top" align="center">332</td>
<td/>
<td valign="top" align="center">228</td>
<td/>
<td valign="top" align="center">3</td>
<td/>
<td valign="top" align="center">6</td>
<td/>
<td valign="top" align="center">3</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">23.70%</td>
<td valign="top" align="center">20.00%</td>
<td valign="top" align="center">40.69%</td>
<td/>
<td valign="top" align="center">48.51%</td>
<td/>
<td valign="top" align="center">4.69%</td>
<td/>
<td valign="top" align="center">25.00%</td>
<td/>
<td valign="top" align="center">18.75%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Perineum and buttocks</td>
<td valign="top" align="center">141</td>
<td valign="top" align="center">83</td>
<td valign="top" align="center">58</td>
<td/>
<td valign="top" align="center">18</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">10</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">3.09%</td>
<td valign="top" align="center">2.22%</td>
<td valign="top" align="center">7.11%</td>
<td/>
<td valign="top" align="center">3.83%</td>
<td/>
<td valign="top" align="center">3.13%</td>
<td/>
<td valign="top" align="center">8.33%</td>
<td/>
<td valign="top" align="center">62.50%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Hands and feet</td>
<td valign="top" align="center">318</td>
<td valign="top" align="center">285</td>
<td valign="top" align="center">33</td>
<td/>
<td valign="top" align="center">6</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">15</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">6.97%</td>
<td valign="top" align="center">7.61%</td>
<td valign="top" align="center">4.04%</td>
<td/>
<td valign="top" align="center">1.28%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">62.50%</td>
<td/>
<td valign="top" align="center">12.50%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Reason for removal</td>
<td/>
<td/>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">&#x0003C;0.001</td>
<td/>
<td valign="top" align="center">0.018</td>
<td/>
<td valign="top" align="center">0.094</td>
<td/>
<td valign="top" align="center">0.261</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Atypical clinical features</td>
<td valign="top" align="center">2152</td>
<td valign="top" align="center">1566</td>
<td valign="top" align="center">586</td>
<td/>
<td valign="top" align="center">328</td>
<td/>
<td valign="top" align="center">54</td>
<td/>
<td valign="top" align="center">16</td>
<td/>
<td valign="top" align="center">13</td>
<td/>
<td valign="top" align="center">4</td>
<td/>
<td valign="top" align="center">2</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">47.18%</td>
<td valign="top" align="center">41.82%</td>
<td valign="top" align="center">71.81%</td>
<td/>
<td valign="top" align="center">69.79%</td>
<td/>
<td valign="top" align="center">84.38%</td>
<td/>
<td valign="top" align="center">66.67%</td>
<td/>
<td valign="top" align="center">81.25%</td>
<td/>
<td valign="top" align="center">100.00%</td>
<td/>
<td valign="top" align="center">100.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Changes in skin lesions</td>
<td valign="top" align="center">30</td>
<td valign="top" align="center">18</td>
<td valign="top" align="center">12</td>
<td/>
<td valign="top" align="center">3</td>
<td/>
<td valign="top" align="center">4</td>
<td/>
<td valign="top" align="center">4</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">0.66%</td>
<td valign="top" align="center">0.48%</td>
<td valign="top" align="center">1.47%</td>
<td/>
<td valign="top" align="center">0.64%</td>
<td/>
<td valign="top" align="center">6.25%</td>
<td/>
<td valign="top" align="center">16.67%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Cosmetic requirements</td>
<td valign="top" align="center">2225</td>
<td valign="top" align="center">2015</td>
<td valign="top" align="center">210</td>
<td/>
<td valign="top" align="center">139</td>
<td/>
<td valign="top" align="center">6</td>
<td/>
<td valign="top" align="center">1</td>
<td/>
<td valign="top" align="center">3</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">48.78%</td>
<td valign="top" align="center">53.81%</td>
<td valign="top" align="center">25.74%</td>
<td/>
<td valign="top" align="center">29.57%</td>
<td/>
<td valign="top" align="center">9.38%</td>
<td/>
<td valign="top" align="center">4.17%</td>
<td/>
<td valign="top" align="center">18.75%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;Repeated stimulation</td>
<td valign="top" align="center">154</td>
<td valign="top" align="center">146</td>
<td valign="top" align="center">8</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">3</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
<td valign="top" align="center">0</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">3.38%</td>
<td valign="top" align="center">3.90%</td>
<td valign="top" align="center">0.98%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">12.50%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
<td valign="top" align="center">0.00%</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN4">
<label>a</label>
<p><italic>Demographic comparison was made between the overall histopathological concordance group and histopathological discordance group</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>In further detail, male sex was significantly associated with a change in diagnosis to seborrheic keratosis, basal cell carcinoma, Bowen&#x00027;s disease, and wart (<italic>p</italic> &#x0003C; 0.001; <xref ref-type="table" rid="T3">Table 3</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>). However, sex had no effect on the change in diagnosis to melanoma (<xref ref-type="table" rid="T3">Table 3</xref>). Old age was significantly correlated with changes in diagnosis to seborrheic keratosis, basal cell carcinoma, melanoma, Bowen&#x00027;s disease, squamous cell carcinoma, keratoacanthoma, epidermoid cyst, and wart (<italic>p</italic> &#x0003C; 0.001; <xref ref-type="table" rid="T3">Table 3</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>). Furthermore, lesions on the trunk and limbs were significantly associated with a change in diagnosis to seborrheic keratosis (48.51%), lesions on the head and neck were significantly associated with a change in diagnosis to basal cell carcinoma (92.19%), lesions on the hands and feet were significantly associated with a change in diagnosis to melanoma (62.50%), and lesions on the perineum and buttocks were significantly associated with changes in diagnosis to Bowen&#x00027;s disease (62.50%) and wart (26.67%), compared with 20.00, 70.17, 7.61, and 2.22%, respectively, in patients with histopathological concordance (<xref ref-type="table" rid="T3">Table 3</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>). More importantly, in addition to atypical clinical features, the percentages of lesions removed due to lesion changes (16.76%) and repeated stimulation (12.50%) were significantly higher among lesions with a change in diagnosis to melanoma than among lesions with a histopathological concordance (0.48 and 3.90%, respectively; <xref ref-type="table" rid="T3">Table 3</xref>). Therefore, clinical characteristics and reasons for removal have a potential impact on misclassification.</p></sec></sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Melanocytic nevi are the most common benign neoplasms of the skin and are also the most easily misdiagnosed skin disease (<xref ref-type="bibr" rid="B5">5</xref>). Our study collected excised lesions clinically diagnosed as melanocytic nevi in a Chinese population over 5 consecutive years. The results showed that the consistency of the clinical and histopathological diagnoses of melanocytic nevi was 82.11% after the histopathological examination. Among them, 90.25% were common acquired melanocytic nevi, and 9.75% were other benign melanocytic neoplasms, such as congenital nevomelanocytic nevi, blue nevi, and lentigo. More importantly, 17.89% of patients were reclassified as having other diseases after the histopathological examination. The most common diagnostic change was to seborrheic keratosis, followed by basal cell carcinoma. Overall, 24 (0.53%) patients were reclassified as having melanoma. In addition, clinical characteristics, such as sex, age, and location of the lesion, and the reasons for removal have a potential impact on misclassification.</p>
<p>Morphologically, common acquired melanocytic nevi are challenging to distinguish from other benign melanocytic neoplasms (<xref ref-type="bibr" rid="B8">8</xref>). Our study found that, among the cases with histopathological concordance, 9.75% were other types of benign melanocytic neoplasms. In addition, the results showed that younger age was significantly associated with the histopathological diagnosis of congenital nevomelanocytic nevus and Spitz nevus, compared with common acquired melanocytic nevi. The reason for the clinical significance of congenital nevomelanocytic nevus (CMN) is the risk of malignancy (<xref ref-type="bibr" rid="B9">9</xref>). The malignancy potential of CMN is well-characterized in congenital melanocytic giant nevi (<xref ref-type="bibr" rid="B10">10</xref>). However, the possibility of melanoma development has also been clearly verified for medium and small nevi (<xref ref-type="bibr" rid="B11">11</xref>). Spitz nevus is predominantly observed in children and adolescents. In children, a Spitz nevus presents as isolated, domed nodules with a smooth surface and a bright red to brown color. In adults, a Spitz nevus is usually dark in color with brown to black papules, nodules, and nodes (<xref ref-type="bibr" rid="B12">12</xref>&#x02013;<xref ref-type="bibr" rid="B14">14</xref>). Because of the difficulty of the clinical diagnosis of Spitz nevus, histopathological examination is necessary (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Therefore, patients should be asked for a detailed medical history, and lesions in younger patients should be differentiated from congenital nevomelanocytic nevus and Spitz nevus. &#x0201C;Dysplastic&#x0201D; melanocytic nevus, also known as atypical melanocytic nevus, is unusually large and variable in form and shows atypical asymmetry, size, borders, and coloration (<xref ref-type="bibr" rid="B7">7</xref>). Moreover, &#x0201C;dysplastic&#x0201D; melanocytic nevus is challenging to distinguish from common acquired melanocytic nevi and melanoma (<xref ref-type="bibr" rid="B17">17</xref>). Importantly, it has been reported that melanoma can develop in &#x0201C;dysplastic&#x0201D; melanocytic nevi with a probability of 1:200 to 1:500 and that the presence of several &#x0201C;dysplastic&#x0201D; melanocytic nevi increases the melanoma risk (<xref ref-type="bibr" rid="B3">3</xref>). Our data found that the percentage of &#x0201C;dysplastic&#x0201D; melanocytic nevus lesions occurring on the lower limbs was higher than that in patients with a histopathological diagnosis of common acquired melanocytic nevi. Therefore, lesions on the lower limbs with atypical clinical features should be given a detailed physical examination and carefully differentiated from common acquired melanocytic nevi.</p>
<p>In this study, 17.89% of lesions were reclassified as other diseases after the histopathological examination. The most common diagnostic change was seborrheic keratosis, a common benign epidermal tumor (<xref ref-type="bibr" rid="B18">18</xref>). Seborrheic keratosis is generally a roundish, scaly, reddish to brownish lesion; it is most common in individuals over 50 years old (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). Clinically, seborrheic keratosis can mimic the appearance of melanocytic tumors (<xref ref-type="bibr" rid="B21">21</xref>). Our study found that male sex, older age, and location of the lesions on the trunk and limbs have a potential impact on the misclassification of seborrheic keratosis. Thus, skin lesions with the above-mentioned characteristics should be differentiated from seborrheic keratosis. More importantly, after the histopathological examination, 1.89% of patients were reclassified as having non-melanoma skin cancer (NMSC), including 64 with basal cell carcinoma, 16 with Bowen&#x00027;s disease, four with squamous cell carcinoma, and two with keratoacanthoma. NMSC is the most common human cancer, and sun exposure is an important risk factor for this disease (<xref ref-type="bibr" rid="B22">22</xref>). In addition, it has been reported that the incidence of NMSC is higher in men than in women, and 80% of cases occur in people aged 60 years and older (<xref ref-type="bibr" rid="B23">23</xref>). Basal cell carcinomas are usually small and have a translucent or pearly appearance (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). Approximately 80% of all basal cell carcinomas occur on the head and neck. Unlike basal cell carcinomas, squamous cell carcinomas can have precursor lesions, such as actinic keratosis and Bowen&#x00027;s disease (<xref ref-type="bibr" rid="B26">26</xref>), and typically develop on sun-exposed sites. These studies support our findings. Our study found that male sex was significantly associated with changes in diagnosis to basal cell carcinoma and Bowen&#x00027;s disease. Old age and sun-exposed sites (head and neck) have a potential impact on the misclassification of NMSC, except for Bowen&#x00027;s disease. Lesions on the perineum and buttocks were significantly related to a change in diagnosis to Bowen&#x00027;s disease. Therefore, melanocytic nevi-like lesions in elderly and/or male patients and on sun-exposed skin should be carefully differentiated from basal cell carcinoma and squamous cell carcinoma, and lesions on the perineum and buttocks should be differentiated from Bowen&#x00027;s disease.</p>
<p>The most important task in the diagnosis of melanocytic nevi is to differentiate these lesions from melanoma. We found that 24 patients were reclassified as having melanoma after the histopathological examination. Sex had no effect on misclassification. However, older age and lesions on the hands and feet were significantly related to a change in diagnosis to melanoma, which might be related to the characteristics of melanoma in China. The incidence of cutaneous melanoma is rising faster than that of any other solid tumor (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>). Superficial spreading melanoma is the most common type of cutaneous melanoma in Caucasians (<xref ref-type="bibr" rid="B29">29</xref>). However, acral melanoma is a common subtype of melanoma in Chinese patients, while it is rare in Caucasian patients (<xref ref-type="bibr" rid="B30">30</xref>&#x02013;<xref ref-type="bibr" rid="B33">33</xref>). Melanoma can develop from pre-existing nevi in approximately 20&#x02013;40% of cases (<xref ref-type="bibr" rid="B34">34</xref>). Early diagnosis is the key to improving the survival rate (<xref ref-type="bibr" rid="B35">35</xref>). The ABCDE rules (asymmetry, border irregularity, color variegation, diameter, and evolution) are useful for the early identification of melanoma (<xref ref-type="bibr" rid="B36">36</xref>). In addition, dermatoscopy improves diagnostic accuracy, particularly in the differential diagnosis between benign and malignant melanocytic tumors. Furthermore, the results showed that, in addition to atypical clinical features, the percentage of lesions removed due to lesion changes and repeated stimulation was significantly higher in lesions whose diagnosis was changed to melanoma than in lesions with histopathological concordance. Therefore, our study shows that melanocytic nevi should be differentiated from melanoma in elderly patients when the lesions are in load-bearing and friction-prone sites or in the event of changes or repeated stimulation.</p>
<p>In summary, our data demonstrate that histopathological review results in a change in diagnosis in 17.89% of patients with the clinical diagnosis of melanocytic nevi. In addition, clinical characteristics have a potential impact on misclassification. In addition to atypical clinical manifestations, lesions in elderly patients, lesions in sun-exposed, load-bearing, or friction-prone locations, and lesions with changes or repeated stimulation should raise the clinical suspect and be carefully differentiated from malignant tumors.</p></sec>
<sec sec-type="data-availability-statement" id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="s9">Supplementary Material</xref>, further inquiries can be directed to the corresponding author/s.</p></sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by the ethics committees of Xiangya hospital of Central South University, Changsha, Hunan, China. Written informed consent to participate in this study was provided by the participants&#x00027; legal guardian/next of kin.</p></sec>
<sec id="s7">
<title>Author Contributions</title>
<p>PL performed the study design, data analysis, and manuscript writing. XZ, MC, XC, JL, and CP contributed to data collection and validation. YK, MC, and XC performed the clinical diagnosis and samples collection. JS, YK, and WZ were clinical experts and performed the manuscript revision. All authors read and approved the final version of the manuscript.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
</body>
<back>
<ack><p>The authors would like to sincerely appreciate all coordinators, dermatologists, and investigators that participated in this study.</p>
</ack>
<sec sec-type="supplementary-material" id="s9">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmed.2021.681668/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmed.2021.681668/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname> <given-names>I</given-names></name></person-group>. <article-title>New and evolving concepts of melanocytic nevi and melanocytomas</article-title>. <source>Mod Pathol.</source> (<year>2020</year>) <volume>33</volume>:<fpage>1</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1038/s41379-019-0390-x</pub-id><pub-id pub-id-type="pmid">31659277</pub-id></citation>
</ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plasmeijer</surname> <given-names>EI</given-names></name> <name><surname>Nguyen</surname> <given-names>TM</given-names></name> <name><surname>Olsen</surname> <given-names>CM</given-names></name> <name><surname>Janda</surname> <given-names>M</given-names></name> <name><surname>Soyer</surname> <given-names>HP</given-names></name> <name><surname>Green</surname> <given-names>AC</given-names></name></person-group>. <article-title>The natural history of common melanocytic nevi: a systematic review of longitudinal studies in the general population</article-title>. <source>J Invest Dermatol.</source> (<year>2017</year>) <volume>137</volume>:<fpage>2017</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jid.2017.03.040</pub-id><pub-id pub-id-type="pmid">28528913</pub-id></citation>
</ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hauschild</surname> <given-names>A</given-names></name> <name><surname>Egberts</surname> <given-names>F</given-names></name> <name><surname>Garbe</surname> <given-names>C</given-names></name> <name><surname>Bauer</surname> <given-names>J</given-names></name> <name><surname>Grabbe</surname> <given-names>S</given-names></name> <name><surname>Hamm</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Melanocytic nevi</article-title>. <source>J Dtsch Dermatol Ges.</source> (<year>2011</year>) <volume>9</volume>:<fpage>723</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1111/j.1610-0387.2011.07741.x</pub-id><pub-id pub-id-type="pmid">21762380</pub-id></citation>
</ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soleymani</surname> <given-names>T</given-names></name> <name><surname>Swetter</surname> <given-names>SM</given-names></name> <name><surname>Hollmig</surname> <given-names>ST</given-names></name> <name><surname>Aasi</surname> <given-names>SZ</given-names></name></person-group>. <article-title>Adequacy of conservative 2- to 3-mm surgical margins for complete excision of biopsy-proven severely dysplastic nevi: Retrospective case series at a tertiary academic institution</article-title>. <source>J Am Acad Dermatol.</source> (<year>2020</year>) <volume>83</volume>:<fpage>254</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaad.2019.12.077</pub-id><pub-id pub-id-type="pmid">31972255</pub-id></citation>
</ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piepkorn</surname> <given-names>MW</given-names></name> <name><surname>Longton</surname> <given-names>GM</given-names></name> <name><surname>Reisch</surname> <given-names>LM</given-names></name> <name><surname>Elder</surname> <given-names>DE</given-names></name> <name><surname>Pepe</surname> <given-names>MS</given-names></name> <name><surname>Kerr</surname> <given-names>KF</given-names></name> <etal/></person-group>. <article-title>Assessment of second-opinion strategies for diagnoses of cutaneous melanocytic lesions</article-title>. <source>JAMA Netw Open.</source> (<year>2019</year>) <volume>2</volume>:<fpage>e1912597</fpage>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.12597</pub-id><pub-id pub-id-type="pmid">31603483</pub-id></citation>
</ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Damsky</surname> <given-names>M</given-names></name> <name><surname>Bosenberg</surname> <given-names>WE</given-names></name></person-group>. <article-title>Melanocytic nevi and melanoma: unraveling a complex relationship</article-title>. <source>Oncogene.</source> (<year>2017</year>) <volume>36</volume>:<fpage>5771</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2017.189</pub-id><pub-id pub-id-type="pmid">28604751</pub-id></citation>
</ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Bolognia</surname> <given-names>JL</given-names></name> <name><surname>Schaffer</surname> <given-names>JV</given-names></name> <name><surname>Cerroni</surname> <given-names>L</given-names></name></person-group>. <source>Dermatology E-Book</source>. Elsevier Health Sciences (<year>2017</year>), <publisher-loc>China</publisher-loc>: <publisher-name>Elsevier</publisher-name>.</citation>
</ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>K</given-names></name> <name><surname>Kim</surname> <given-names>D</given-names></name> <name><surname>Mohan</surname> <given-names>LS</given-names></name> <name><surname>Garfield</surname> <given-names>EM</given-names></name> <name><surname>Quan</surname> <given-names>VL</given-names></name> <name><surname>Zhang</surname> <given-names>B</given-names></name> <etal/></person-group>. <article-title>A retrospective cohort study of the diagnostic value of different subtypes of atypical pigment network on dermoscopy</article-title>. <source>J Am Acad Dermatol.</source> (<year>2020</year>) <volume>83</volume>:<fpage>1028</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaad.2020.05.080</pub-id><pub-id pub-id-type="pmid">32446823</pub-id></citation>
</ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polubothu</surname> <given-names>S</given-names></name> <name><surname>McGuire</surname> <given-names>N</given-names></name> <name><surname>Al-Olabi</surname> <given-names>L</given-names></name> <name><surname>Baird</surname> <given-names>W</given-names></name> <name><surname>Bulstrode</surname> <given-names>N</given-names></name> <name><surname>Chalker</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi</article-title>. <source>Br J Dermatol.</source> (<year>2020</year>) <volume>182</volume>:<fpage>434</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1111/bjd.18106</pub-id><pub-id pub-id-type="pmid">31111470</pub-id></citation>
</ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oei</surname> <given-names>W</given-names></name> <name><surname>Fledderus</surname> <given-names>AC</given-names></name> <name><surname>Spuls</surname> <given-names>PI</given-names></name> <name><surname>Eggen</surname> <given-names>CAM</given-names></name> <name><surname>Kottner</surname> <given-names>J</given-names></name> <name><surname>van der Horst</surname> <given-names>CMAM</given-names></name> <etal/></person-group>. <article-title>Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step towards a core outcome set for clinical practice and research</article-title>. <source>Br J Dermatol</source>. (<year>2020</year>). <pub-id pub-id-type="doi">10.1111/bjd.19694</pub-id></citation>
</ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Illig</surname> <given-names>L</given-names></name> <name><surname>Weidner</surname> <given-names>F</given-names></name> <name><surname>Hundeiker</surname> <given-names>M</given-names></name> <name><surname>Gartmann</surname> <given-names>H</given-names></name> <name><surname>Biess</surname> <given-names>B</given-names></name> <name><surname>Leyh</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>Congenital nevi less than or equal to 10 cm as precursors to melanoma. 52 cases, a review, and a new conception</article-title>. <source>Arch Dermatol.</source> (<year>1985</year>) <volume>121</volume>:<fpage>1274</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1001/archderm.121.10.1274</pub-id><pub-id pub-id-type="pmid">4037820</pub-id></citation>
</ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pollock</surname> <given-names>JL</given-names></name></person-group>. <article-title>Dermoscopic patterns of spitz nevi</article-title>. <source>JAMA.</source> (<year>2018</year>) <volume>319</volume>:<fpage>194</fpage>. <pub-id pub-id-type="doi">10.1001/jama.2017.18991</pub-id></citation>
</ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elder</surname> <given-names>DE</given-names></name> <name><surname>Barnhill</surname> <given-names>RL</given-names></name></person-group>. <article-title>The pink papules and plaques of Spitz</article-title>. <source>Br J Dermatol.</source> (<year>2019</year>) <volume>181</volume>:<fpage>235</fpage>. <pub-id pub-id-type="doi">10.1111/bjd.18160</pub-id><pub-id pub-id-type="pmid">31368522</pub-id></citation>
</ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soura</surname> <given-names>E</given-names></name> <name><surname>Plaka</surname> <given-names>M</given-names></name> <name><surname>Stefanaki</surname> <given-names>C</given-names></name> <name><surname>Chasapi</surname> <given-names>V</given-names></name> <name><surname>Christofidou</surname> <given-names>E</given-names></name> <name><surname>Antoniou</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Characteristics of Spitz nevi, Atypical Spitz nevi and Melanomas in patients younger than 20 years</article-title>. <source>J Eur Acad Dermatol Venereol.</source> (<year>2017</year>) <volume>31</volume>:<fpage>e384</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1111/jdv.14208</pub-id><pub-id pub-id-type="pmid">28295655</pub-id></citation>
</ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scalvenzi</surname> <given-names>M</given-names></name> <name><surname>Costa</surname> <given-names>C</given-names></name> <name><surname>De Fata Salvatores</surname> <given-names>G</given-names></name> <name><surname>Cappello</surname> <given-names>M</given-names></name> <name><surname>Villani</surname> <given-names>A</given-names></name></person-group>. <article-title>Clinical and dermoscopic features of Spitz naevus by sex, age and anatomical site: a study of 913 Spitz naevi</article-title>. <source>Br J Dermatol.</source> (<year>2018</year>) <volume>179</volume>:<fpage>769</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1111/bjd.16564</pub-id><pub-id pub-id-type="pmid">29569227</pub-id></citation>
</ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soura</surname> <given-names>E</given-names></name> <name><surname>Dimitrakopoulou</surname> <given-names>A</given-names></name> <name><surname>Christofidou</surname> <given-names>E</given-names></name> <name><surname>Katoulis</surname> <given-names>A</given-names></name> <name><surname>Antoniou</surname> <given-names>C</given-names></name> <name><surname>Stratigos</surname> <given-names>A</given-names></name></person-group>. <article-title>Patients with spitz naevi in the greek population: epidemiologic, clinical, and histopathological characteristics</article-title>. <source>J Eur Acad Dermatol Venereol.</source> (<year>2018</year>) <volume>32</volume>:<fpage>1128</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1111/jdv.14702</pub-id><pub-id pub-id-type="pmid">29150877</pub-id></citation>
</ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sondermann</surname> <given-names>W</given-names></name> <name><surname>Utikal</surname> <given-names>JS</given-names></name> <name><surname>Enk</surname> <given-names>AH</given-names></name> <name><surname>Schadendorf</surname> <given-names>D</given-names></name> <name><surname>Klode</surname> <given-names>J</given-names></name> <name><surname>Hauschild</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Prediction of melanoma evolution in melanocytic nevi <italic>via</italic> artificial intelligence: a call for prospective data</article-title>. <source>Eur J Cancer.</source> (<year>2019</year>) <volume>119</volume>:<fpage>30</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejca.2019.07.009</pub-id><pub-id pub-id-type="pmid">31401471</pub-id></citation>
</ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hafner</surname> <given-names>C</given-names></name> <name><surname>Vogt</surname> <given-names>T</given-names></name></person-group>. <article-title>Seborrheic keratosis</article-title>. <source>J Dtsch Dermatol Ges.</source> (<year>2008</year>) <volume>6</volume>:<fpage>664</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1111/j.1610-0387.2008.06788.x</pub-id><pub-id pub-id-type="pmid">18801147</pub-id></citation>
</ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karadag</surname> <given-names>AS</given-names></name> <name><surname>Parish</surname> <given-names>LC</given-names></name></person-group>. <article-title>The status of the seborrheic keratosis</article-title>. <source>Clin Dermatol.</source> (<year>2018</year>) <volume>36</volume>:<fpage>275</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.clindermatol.2017.09.011</pub-id><pub-id pub-id-type="pmid">29566932</pub-id></citation>
</ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname> <given-names>RP</given-names></name> <name><surname>Ludwig</surname> <given-names>S</given-names></name> <name><surname>Marghoob</surname> <given-names>AA</given-names></name></person-group>. <article-title>Differential diagnosis of seborrheic keratosis: clinical and dermoscopic features</article-title>. <source>J Drugs Dermatol.</source> (<year>2017</year>) <volume>16</volume>:<fpage>835</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">28915278</pub-id></citation>
</ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minagawa</surname> <given-names>A</given-names></name></person-group>. <article-title>Dermoscopy-pathology relationship in seborrheic keratosis</article-title>. <source>J Dermatol.</source> (<year>2017</year>) <volume>44</volume>:<fpage>518</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1111/1346-8138.13657</pub-id><pub-id pub-id-type="pmid">28447350</pub-id></citation>
</ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Madan</surname> <given-names>V</given-names></name> <name><surname>Lear</surname> <given-names>JT</given-names></name> <name><surname>Szeimies</surname> <given-names>RM</given-names></name></person-group>. <article-title>Non-melanoma skin cancer</article-title>. <source>Lancet.</source> (<year>2010</year>) <volume>375</volume>:<fpage>673</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(09)61196-X</pub-id><pub-id pub-id-type="pmid">20171403</pub-id></citation>
</ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diffey</surname> <given-names>BL</given-names></name> <name><surname>Langtry</surname> <given-names>JA</given-names></name></person-group>. <article-title>Skin cancer incidence and the ageing population</article-title>. <source>Br J Dermatol.</source> (<year>2005</year>) <volume>153</volume>:<fpage>679</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2133.2005.06799.x</pub-id><pub-id pub-id-type="pmid">16120172</pub-id></citation>
</ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Basset-Seguin</surname> <given-names>N</given-names></name> <name><surname>Herms</surname> <given-names>F</given-names></name></person-group>. <article-title>Update in the management of basal cell carcinoma</article-title>. <source>Acta Derm Venereol.</source> (<year>2020</year>) <volume>100</volume>:<fpage>adv00140</fpage>. <pub-id pub-id-type="doi">10.2340/00015555-3495</pub-id><pub-id pub-id-type="pmid">32346750</pub-id></citation>
</ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rubin</surname> <given-names>AI</given-names></name> <name><surname>Chen</surname> <given-names>EH</given-names></name> <name><surname>Ratner</surname> <given-names>D</given-names></name></person-group>. <article-title>Basal-cell carcinoma</article-title>. <source>N Engl J Med</source>. (<year>2005</year>) <volume>353</volume>:<fpage>2262</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra044151</pub-id><pub-id pub-id-type="pmid">16306523</pub-id></citation>
</ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fania</surname> <given-names>L</given-names></name> <name><surname>Didona</surname> <given-names>D</given-names></name> <name><surname>Di Pietro</surname> <given-names>FR</given-names></name> <name><surname>Verkhovskaia</surname> <given-names>S</given-names></name> <name><surname>Morese</surname> <given-names>R</given-names></name> <name><surname>Paolino</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Cutaneous squamous cell carcinoma: from pathophysiology to novel therapeutic approaches</article-title>. <source>Biomedicines.</source> (<year>2021</year>) <volume>9</volume>:<fpage>171</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines9020171</pub-id><pub-id pub-id-type="pmid">33572373</pub-id></citation>
</ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gershenwald</surname> <given-names>JE</given-names></name> <name><surname>Ross</surname> <given-names>MI</given-names></name></person-group>. <article-title>Sentinel-lymph-node biopsy for cutaneous melanoma</article-title>. <source>N Engl J Med.</source> (<year>2011</year>) <volume>364</volume>:<fpage>1738</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMct1002967</pub-id><pub-id pub-id-type="pmid">21542744</pub-id></citation>
</ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eggermont</surname> <given-names>AM</given-names></name> <name><surname>Spatz</surname> <given-names>A</given-names></name> <name><surname>Robert</surname> <given-names>C</given-names></name></person-group>. <article-title>Cutaneous melanoma</article-title>. <source>Lancet.</source> (<year>2014</year>) <volume>383</volume>:<fpage>816</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)60802-8</pub-id><pub-id pub-id-type="pmid">24054424</pub-id></citation>
</ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Susok</surname> <given-names>L</given-names></name> <name><surname>Gambichler</surname> <given-names>T</given-names></name></person-group>. <article-title>Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma</article-title>. <source>J Cancer Res Clin Oncol</source>. (<year>2021</year>). <pub-id pub-id-type="doi">10.1007/s00432-021-03630-6</pub-id></citation>
</ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>K</given-names></name> <name><surname>Xu</surname> <given-names>Y</given-names></name> <name><surname>Gabriel</surname> <given-names>EM</given-names></name> <name><surname>Misra</surname> <given-names>S</given-names></name> <name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Bagaria</surname> <given-names>SP</given-names></name></person-group>. <article-title>Comparative analysis of acral melanoma in chinese and caucasian patients</article-title>. <source>J Skin Cancer.</source> (<year>2020</year>) <volume>2020</volume>:<fpage>5169051</fpage>. <pub-id pub-id-type="doi">10.21203/rs.2.22789/v1</pub-id><pub-id pub-id-type="pmid">33083061</pub-id></citation>
</ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname> <given-names>RJ</given-names></name></person-group>. <article-title>Melanoma in the Chinese of Hong Kong. Emphasis on volar and subungual sites</article-title>. <source>Cancer.</source> (<year>1984</year>) <volume>54</volume>:<fpage>1482</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/1097-014254:7&#x0003C;1482::AID&#x02013;CNCR2820540745&#x0003E;3.0.CO;2-O</pub-id><pub-id pub-id-type="pmid">6467173</pub-id></citation>
</ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname> <given-names>J</given-names></name> <name><surname>Dai</surname> <given-names>B</given-names></name> <name><surname>Kong</surname> <given-names>Y</given-names></name> <name><surname>Shen</surname> <given-names>X</given-names></name> <name><surname>Kong</surname> <given-names>J</given-names></name></person-group>. <article-title>Acral melanoma in Chinese: a clinicopathological and prognostic study of 142 cases</article-title>. <source>Sci Rep.</source> (<year>2016</year>) <volume>6</volume>:<fpage>31432</fpage>. <pub-id pub-id-type="doi">10.1038/srep31432</pub-id><pub-id pub-id-type="pmid">27545198</pub-id></citation>
</ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>J</given-names></name> <name><surname>Luo</surname> <given-names>X</given-names></name> <name><surname>Huang</surname> <given-names>H</given-names></name> <name><surname>Zhai</surname> <given-names>Z</given-names></name> <name><surname>Shen</surname> <given-names>Z</given-names></name> <name><surname>Lin</surname> <given-names>H</given-names></name></person-group>. <article-title>Clinical characteristics of malignant melanoma in southwest China: a single-center series of 82 consecutive cases and a meta-analysis of 958 reported cases</article-title>. <source>PLoS ONE.</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0165591</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0165591</pub-id><pub-id pub-id-type="pmid">27861496</pub-id></citation>
</ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elder</surname> <given-names>DE</given-names></name></person-group>. <article-title>Precursors to melanoma and their mimics: nevi of special sites</article-title>. <source>Mod Pathol.</source> (<year>2006</year>) <volume>19</volume>(<supplement>Suppl. 2</supplement>):<fpage>S4</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1038/modpathol.3800515</pub-id><pub-id pub-id-type="pmid">16446715</pub-id></citation>
</ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schadendorf</surname> <given-names>D</given-names></name> <name><surname>van Akkooi</surname> <given-names>ACJ</given-names></name> <name><surname>Berking</surname> <given-names>C</given-names></name> <name><surname>Griewank</surname> <given-names>KG</given-names></name> <name><surname>Gutzmer</surname> <given-names>R</given-names></name> <name><surname>Hauschild</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Melanoma</article-title>. <source>Lancet.</source> (<year>2018</year>) <volume>392</volume>:<fpage>971</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(18)31559-9</pub-id><pub-id pub-id-type="pmid">30238891</pub-id></citation>
</ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><collab>American Academy of Dermatology Ad Hoc Task Force for the ABCDEs of Melanoma Tsao H Olazagasti JM Cordoro KM Brewer JD Taylor SC </collab></person-group>. <article-title>Early detection of melanoma: reviewing the ABCDEs</article-title>. <source>J Am Acad Dermatol.</source> (<year>2015</year>) <volume>72</volume>:<fpage>717</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaad.2015.01.025</pub-id><pub-id pub-id-type="pmid">25698455</pub-id></citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by the National Natural Science Foundation of China (81430075, 81773329, and 81974479) and the Hunan Provincial Innovation Foundation for Postgraduate (2020zzts251).</p>
</fn>
</fn-group>
</back>
</article>